Allison Dorval

Companies

• Verve Therapeutics, Inc.Chief financial officer Nov 30, 2021 to now¹
• Puma BiotechnologyBoard member Jul 16, 2021 to now²
• Jade Biosciences, Inc.Board member Jul 19, 2021 to Jun 7, 2024³
• Voyager Therapeutics (United States)Chief financial officer Nov 9, 2018 to Mar 23, 2021⁴
• Voyager Therapeutics (United States)Vice President, Finance Jun 15, 2018 to Jun 15, 2018⁵
• Insulet (United States)Chief financial officer Nov 17, 2014 to Apr 3, 2015⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PBPuma Biotechnology PBYI90,780 shares⁷$969.5K at $10.68Jun 12, 2026
• VTVerve Therapeutics, Inc.0 shares⁸Jul 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 12, 2026Sold 11,610 shares at $7.20 of Puma Biotechnology⁷
• Jun 11, 2026Granted 27,000 shares of Puma Biotechnology⁷
• Jul 25, 2025U 13,280 shares of Verve Therapeutics, Inc.⁸
• Jun 13, 2025Sold 11,610 shares at $3.40 of Puma Biotechnology⁹
• Jun 11, 2025Granted 27,000 shares of Puma Biotechnology¹⁰
• Apr 2, 2025Sold 3,350 shares at $4.15 of Verve Therapeutics, Inc.¹¹
• Apr 1, 2025Exercised options 11,250 shares of Verve Therapeutics, Inc.¹¹
• Dec 2, 2024Sold 555 shares at $5.64 of Verve Therapeutics, Inc.¹²
• Nov 29, 2024Exercised options 1,875 shares of Verve Therapeutics, Inc.¹²
• Jun 18, 2024Granted 27,000 shares of Puma Biotechnology¹³
• Jun 13, 2024Sold 11,000 shares at $3.37 of Puma Biotechnology¹⁴
• Nov 29, 2023Sold 554 shares at $11.45 of Verve Therapeutics, Inc.¹⁵
• Nov 29, 2023Exercised options 1,875 shares of Verve Therapeutics, Inc.¹⁵
• Jun 13, 2023Granted 27,000 shares of Puma Biotechnology¹⁶
• Jun 13, 2023Sold 10,000 shares at $3.45 of Puma Biotechnology¹⁶
• Nov 29, 2022Sold 554 shares at $22.10 of Verve Therapeutics, Inc.¹⁷
• Nov 29, 2022Exercised options 1,875 shares of Verve Therapeutics, Inc.¹⁷
• Jun 14, 2022Granted 27,000 shares of Puma Biotechnology¹⁸